Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | APEX1 | P27695 | 1/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | SRD5A1 | P18405 | 5/20 | 0.44 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.40 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chlormezanone SCHEMBL117870 | 1.00 | LMNA (1.00) | LMNATHRBAPEX1PMP22TSHR | |
| Dichlormezanone SCHEMBL2107746 | 0.84 | LMNA (0.72) | LMNATHRBAPEX1PMP22TSHR | |
| Chlormezanone SCHEMBL28086474 | 0.82 | LMNA (0.67) | LMNATHRBAPEX1PMP22TSHR | |
| Chlormezanone SCHEMBL20770956 | 0.78 | LMNA (0.61) | LMNATHRBAPEX1PMP22TSHR | |
| SCHEMBL22781363 | 0.70 | SRD5A1 (0.57) | LMNATHRBAPEX1PMP22TSHR | |
| SCHEMBL11479651 | 0.63 | KMT2A (0.51) | LMNATHRBAPEX1PMP22TSHR | |
| SCHEMBL15972077 | 0.62 | MDM2 (0.80) | LMNATHRBAPEX1PMP22TSHR | |
| SCHEMBL15972076 | 0.62 | MDM2 (0.80) | LMNATHRBAPEX1PMP22TSHR | |
| SCHEMBL15989532 | 0.62 | MDM2 (0.80) | LMNATHRBAPEX1PMP22TSHR | |
| SCHEMBL15972579 | 0.62 | MDM2 (0.80) | LMNATHRBAPEX1PMP22TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2288 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250213593-A1 | Use of Derivatives based on Sarsasapogenin Structure and Pharmaceutical Compositions thereof | BEIJING PHYTOVENT PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2025-07-03 | — | — | US | claimed |
| CN-120025976-A | Method for differentiating hematopoietic stem/progenitor cells into granulocytes | 苏州血霁生物科技有限公司 | 2025-05-23 | — | — | CN | claimed |
| US-20250163379-A1 | METHOD FOR DIFFERENTIATING HEMATOPOIETIC STEM/PROGENITOR CELLS INTO NK CELLS | HEMACELL BIOTECHNOLOGY INC. (CN) | 2025-05-22 | — | — | US | claimed |
| WO-2025062440-A1 | TOPICAL NANO-DISPERSION COMPOSITIONS AND THEIR PREPARATION THEREOF | PULSE PHARMACEUTICALS PVT. LTD (IN) | 2025-03-27 | — | — | WO | claimed |
| EP-4525870-A1 | METHODS OF TREATING CUSHING'S SYNDROME AND LIVER DISORDERS, AND OF REDUCING LIVER TOXICITY OF OTHER DRUGS ADMINISTERED TO A PATIENT | Corcept Therapeutics Incorporated (US) | 2025-03-26 | — | — | EP | claimed |
| CN-119317433-A | Methods for treating cushing's syndrome and liver disease and reducing hepatotoxicity of other drugs taken by patients | 科赛普特治疗学股份有限公司 | 2025-01-14 | — | — | CN | claimed |
| EP-4477225-A1 | USE OF SARSASAPOGENIN STRUCTURE-BASED DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF | Beijing Phytovent Pharmaceutical Technology Co., Ltd. (CN) | 2024-12-18 | — | — | EP | claimed |
| CN-118931541-A | Tungsten/titanium nitride etching solution for avoiding intermetallic electrochemical corrosion effect | 湖北兴福电子材料股份有限公司 | 2024-11-12 | — | — | CN | claimed |
| CN-118786209-A | Method for differentiating hematopoietic stem/progenitor cells into NK cells | 苏州血霁生物科技有限公司 | 2024-10-15 | — | — | CN | claimed |
| US-20240245659-A1 | Methods of Treating Cushing's Syndrome and Liver Disorders, and of Reducing Liver Toxicity of Other Drugs Administered to a Patient | CORCEPT THERAPEUTICS INCORPORATED (US) | 2024-07-25 | — | — | US | claimed |
| EP-0209403-B1 | PROCESS FOR PREPARING ULTRAFINE PARTICLES OF ORGANIC COMPOUNDS | Research Development Corporation of Japan (JP) | 1991-10-23 | — | — | EP | claimed |
| US-4913865-A | Process for preparing ultrafine particles of organic compounds | RESEARCH DEVELOPMENT CORP OF JAPAN (JP) | 1990-04-03 | — | — | US | claimed |
| US-4780463-A | CONTAINING PROPIONIC ACID COMPOUNDS | ANALGESIC ASSOCIATES (US) | 1988-10-25 | — | — | US | claimed |
| EP-0209403-A2 | Process for preparing ultrafine particles of organic compounds | Research Development Corporation of Japan (JP) | 1987-01-21 | — | — | EP | claimed |
| EP-0205492-A1 | ANALGESIC, ANTI-INFLAMMATORY AND SKELETAL MUSCLE RELAXANT COMPOSITIONS | SUNSHINE, Abraham (US) | 1986-12-30 | — | — | EP | claimed |
| WO-1986003681-A1 | ANALGESIC, ANTI-INFLAMMATORY AND SKELETAL MUSCLE RELAXANT COMPOSITIONS | SUNSHINE ABRAHAM | 1986-07-03 | — | — | WO | claimed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | claimed |
| US-4540602-A | Process for the preparation of activated pharmaceutical compositions | FREUND INDUSTRY COMPANY, LIMITED (JP) | 1985-09-10 | — | — | US | claimed |
| US-4181719-A | Analgesic N-acetyl-para-aminophenyl N'-acetylaminothioalkanoates | STERLING DRUG INC. (US) | 1980-01-01 | — | — | US | claimed |
| US-4175119-A | Composition and method to prevent accidental and intentional overdosage with psychoactive drugs | PORTER GARRY L | 1979-11-20 | — | — | US | claimed |